Elsevier

Epilepsy Research

Volume 73, Issue 2, February 2007, Pages 173-180
Epilepsy Research

Amelioration of water maze performance deficits by topiramate applied during pilocarpine-induced status epilepticus is negatively dose-dependent

https://doi.org/10.1016/j.eplepsyres.2006.10.001Get rights and content

Summary

Temporal lobe epilepsy is characterized by a progressive loss of memory capacities, due to sclerosis and functional impairment of mesiotemporal brain areas. We have shown recently that topiramate (TPM) dose-dependently protects hippocampal CA1 and CA3 neurons during initial status epilepticus in the rat pilocarpine model of temporal lobe epilepsy by inhibition of mitochondrial transition pore opening. In the present study, in order to evaluate possible positive effects of the treatment on learning and memory, we investigated water maze performance of rats receiving different dosages of TPM (20 and 100 mg/kg) after 40 min and 4 mg/kg diazepam after 160 min of pilocarpine-induced status epilepticus in relation to performance of animals receiving 4 mg/kg diazepam after 40 min of SE, and to performance of sham-treated control animals. Unexpectedly, 20 but not 100 mg/kg TPM significantly extenuated short-term memory deficits. While neuroprotective effects of TPM were observed in hippocampal CA subfields of animals treated with 100 mg/kg TPM, cell loss in rats treated with 20 mg/kg TPM was indistinguishable from animals receiving diazepam only. The present results indicate a negative dose-dependency of memory-saving effects of TPM applied during status epilepticus apparently dissociated from hippocampal neuroprotection.

Introduction

In the pharmacological treatment of partial epilepsies, topiramate (TPM) was shown to be effective as add-on therapy (Reife et al., 2000, Fritz et al., 2005, Kalviainen et al., 2005) as well as a first line antiepileptic drug (Arroyo et al., 2005). It has a broad spectrum of antiepileptic actions related to its anticonvulsive effects, as current attenuation at voltage-gated sodium-channels (Zona et al., 1997), potentiation of GABA activities (White et al., 1997), or modulation of calcium channels (Zhang et al., 2000). Besides its efficacy with regard to seizures, TPM can induce cognitive impairments which are reversible with discontinuation (Kockelmann et al., 2003, Mula et al., 2003).

Pilocarpine-induced status epilepticus (SE) in the rat is a well-established model of temporal lobe epilepsy reproducing main characteristics of the disease (see Holmes et al., 2002, Löscher, 2002). After SE, rats exhibit a “silent” seizure-free phase characterized by development of extensive damage in hippocampal structures crucially involved in spatial memory (see Silva et al., 1998, Pothuizen et al., 2004), followed by occurrence of spontaneous seizures over the entire life span. Persisting cognitive deficits, observable several days after induction of SE (Rice et al., 1998, Detour et al., 2005, Niessen et al., 2005), are sensitive to pharmacological and environmental interventions during and after SE (Stewart and Persinger, 2001, Faverjon et al., 2002, Pitkanen and Kubova, 2004).

TPM was effective in SE suppression in patients (Blumkin et al., 2005) and in animal models (Fisher et al., 2004). It was shown that TPM, applied during pilocarpine-induced SE in the rat, dose-dependently increased status survival rate and saved hippocampal CA1 and CA3 neurons by protection of hippocampal mitochondria against external calcium challenge (Rigoulot et al., 2003, Kudin et al., 2004). Recently, beneficial effects of TPM application after experimental induction of seizures on cognitive functions were described: chronic administration after pilocarpine-induced SE in weanling rats or after fluoroethyl-induced multiple seizures during P0–P4 led to a reduction of impairments in subsequent water maze performance, while no effects on SE-induced hippocampal cell loss were observed (Cha et al., 2002). The same TPM treatment regimen applied after fluoroethyl-induced seizures during P10–P14 also diminishes water maze deficits, while seizure induction at this age had no effect on neuronal density in CA areas (Zhao et al., 2005). These results indicate that appearance and degree of neuroprotective effects and inhibition of dysfunctional reactive neuronal outgrowth by TPM depend on the modus of seizure induction, application time, and application schedule. Furthermore, behavioral impairment after SE is related to the age of animals and is more pronounced in adult rats (Kubova et al., 2004, Liu et al., 1994). Until now, there are no studies investigating memory effects of TPM applied during SE. Therefore, we investigated effects of TPM application during pilocarpine-induced SE on water maze performance in young adult rats.

Section snippets

Animals

Male Wistar rats (Charles River) 35-days old and weighting 120–170 g at the day before pilocarpine injection were used. During the silent period, they were single housed with food and water ad libitum. Mean weight at the beginning of water maze testing was 324.0 g ± 37.7 (S.D.) and increased to 345.9 g ± 38.5 (S.D.) at the end of testing.

Pilocarpine model of epilepsy

Animals were injected with pilocarpine (340 mg/kg i.p.) 30 min after an injection of methylscopolamine (1 mg/kg i.p.). Seizure activity commenced 20–40 min after

Pilocarpine-induced status epilepticus

As before, application of TPM during status epilepticus had significant live-saving properties: while only 6% of animals survived prolongation of pilocarpine-induced SE for 120 min (see Kudin et al., 2004), 78% (14/18) of the animals receiving 20 mg/kg TPM and 100% of the animals receiving 100 mg/kg TPM (17/17) after 40 min endured SE until termination by diazepam after additional 120 min. Furthermore, TPM-treated animals were not different from animals receiving diazepam after 40 min in terms of

Discussion

In the present study, after recently having shown a neuroprotective effect of TPM on hippocampal structures when applied during pilocarpine-induced status epilepticus, we investigated whether the TPM treatment might reduce status-induced impairment of hippocampus-related memory performance. Indeed, memory-protecting effects of topiramate applied during SE were observed, but, against our expectation, these were negatively dose-dependent. Twenty milligrams per kilogram TPM but not 100 mg/kg TPM

References (64)

  • S. Johnstone et al.

    Delay, discriminatory, and modality specific neurons in striatum and pallidum during short-term memory tasks

    Brain Res.

    (1990)
  • E. Kockelmann et al.

    Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of topiramate in epilepsy patients

    Epilepsy Res.

    (2003)
  • O. Lehmann et al.

    Combined 192 IgG-saporin and 5,7-dihydroxytryptamine lesions in the male rat brain: a neurochemical and behavioral study

    Pharmacol. Biochem. Behav.

    (2002)
  • S.R. Lee et al.

    Protective effect of topiramate against hippocampal neuronal damage after global ischemia in the gerbils

    Neurosci. Lett.

    (2000)
  • Z. Liu et al.

    Long-term behavioral deficits following pilocarpine seizures in immature rats

    Epilepsy Res.

    (1994)
  • W. Löscher

    Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy

    Epilepsy Res.

    (2002)
  • E. Miyoshi et al.

    Impaired learning in a spatial working memory version and in a cued version of the water maze in rats with MPTP-induced mesencephalic dopaminergic lesions

    Brain Res. Bull.

    (2002)
  • M. Niebauer et al.

    Topiramate reduces neuronal injury after experimental status epilepticus

    Brain Res.

    (1999)
  • M. Okada et al.

    Biphasic actions of topiramate on monoamine exocytosis associated with both soluble N-ethylmaleimide-sensitive factor attachment protein receptors and Ca(2+)-induced Ca(2+)-releasing systems

    Neuroscience

    (2005)
  • R.J. Racine

    Modification of seizure activity by electrical stimulation: II. Motor seizure

    Electroencephalogr. Clin. Neurophysiol.

    (1972)
  • R. Schmidt-Kastner et al.

    Glial cell-line derived neurotrophic factor (GDNF) mRNA upregulation in striatum and cortical areas after pilocarpine-induced status epilepticus in rats

    Brain Res. Mol. Brain Res.

    (1994)
  • R.P. Shank et al.

    Plasma and whole blood pharmacokinetics of topiramate: the role of carbonic anhydrase

    Epilepsy Res.

    (2005)
  • H.E. Shannon et al.

    Effects of antiepileptic drugs on working memory as assessed by spatial alternation performance in rats

    Epilepsy Behav.

    (2004)
  • A.J. Silva et al.

    Molecular, cellular, and neuroanatomical substrates of place learning

    Neurobiol. Learn. Mem.

    (1998)
  • L.S. Stewart et al.

    Ketamine prevents learning impairment when administered immediately after status epilepticus onset

    Epilepsy Behav.

    (2001)
  • H.S. White et al.

    Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold

    Epilepsy Res.

    (1997)
  • Y. Yang et al.

    Enhanced neuroprotection and reduced hemorrhagic incidence in focal cerebral ischemia of rat by low dose combination therapy of urokinase and topiramate

    Neuropharmacology

    (2000)
  • Q. Zhao et al.

    Effect of topiramate on cognitive function and activity level following neonatal seizures

    Epilepsy Behav.

    (2005)
  • C. Zona et al.

    Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells

    Neurosci. Lett.

    (1997)
  • M. Abercombie

    Estimation of nuclear population from microtome sections

    Anat. Rec.

    (1946)
  • S. Arroyo et al.

    Randomized dose-controlled study of topiramate as first-line therapy in epilepsy

    Acta Neurol. Scand.

    (2005)
  • K.R. Bailey et al.

    Lesions of specific and nonspecific thalamic nuclei affect prefrontal cortex-dependent aspects of spatial working memory

    Behav. Neurosci.

    (2005)
  • Cited by (33)

    • The anticonvulsant effect of chronic treatment with topiramate after pilocarpine-induced status epilepticus is accompanied by a suppression of comorbid behavioral impairments and robust neuroprotection in limbic regions in rats

      2022, Epilepsy and Behavior
      Citation Excerpt :

      Next-generation antiseizure medications are a subject of an ongoing investigation in terms of their ability to counteract underlying causes of pathogenesis, namely neuroinflammation and oxidative stress. Topiramate (TPM) is a second-line drug, widely applied in clinical practice with several mechanisms of action, including modulation of voltage-activated sodium and L-type calcium channels, potentiating γ-aminobutyric acid (GABA)-mediated chloride influx, and blocking glutamatergic α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid and kainic acid receptors [15]. Although the anticonvulsant activity of TPM is well established, the effects on behavioral responses are also a subject of research.

    • Novel therapeutic approaches for disease-modification of epileptogenesis for curing epilepsy

      2017, Biochimica et Biophysica Acta - Molecular Basis of Disease
    • Topiramate promotes neurological recovery in a new model of traumatic brain injury in rats

      2011, Neuroscience
      Citation Excerpt :

      However, in experimental models of brain ischemia, topiramate at a dose range between 10 and 40 mg/kg statistically significantly improved the post-injury clinical performance and the effect was dose-dependent, while another study found that doses of topiramate more than 40 mg/kg caused mild neurological deterioration in healthy animals (Edmonds et al., 2001; Yang et al., 1998, 2000). In an experimental model of epileptic seizures a dose of 20 mg proved effective as opposed to the dose of 100 mg (Frisch et al., 2007). Therefore in brain trauma, similarly to some other experimental models of acute CNS injury, there is a ceiling effect of the neuroprotective properties of topiramate.

    View all citing articles on Scopus
    View full text